277 related articles for article (PubMed ID: 38112741)
1. Transcatheter left atrial appendage occlusion in patients with chronic kidney disease: a systematic review and meta-analysis.
Flores-Umanzor E; Asghar A; Cepas-Guillén PL; Farrell A; Keshvara R; Alvarez-Rodriguez L; Osten M; Freixa X; Horlick E; Abrahamyan L
Clin Res Cardiol; 2023 Dec; ():. PubMed ID: 38112741
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous left atrial appendage closure, a safe alternative to anticoagulation for patients with nonvalvular atrial fibrillation and end-stage renal disease on hemodialysis: A single center experience.
Xipell M; Flores-Umanzor E; Ojeda R; Arias M; Cepas-Guillén PL; Regueiro A; Freixa X; Cases A; Maduell F
Artif Organs; 2020 May; 44(5):513-521. PubMed ID: 31715006
[TBL] [Abstract][Full Text] [Related]
3. Association of chronic kidney disease and end-stage renal disease with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: Insights from the national inpatient sample of 36,065 procedures.
Munir MB; Khan MZ; Darden D; Nishimura M; Vanam S; Pasupula DK; Asad ZUA; Bhagat A; Zahid S; Osman M; Balla S; Han FT; Reeves R; Hsu JC
Heart Rhythm O2; 2021 Oct; 2(5):472-479. PubMed ID: 34667962
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of patients with chronic kidney disease undergoing left atrial appendage closure for atrial fibrillation.
Liu C; Han S; Cui K; Wang F
PLoS One; 2023; 18(10):e0287928. PubMed ID: 37883421
[TBL] [Abstract][Full Text] [Related]
5. Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk.
Brockmeyer M; Wolff G; Krieger T; Lin Y; Karathanos A; Afzal S; Zeus T; Westenfeld R; Polzin A; Heinen Y; Perings S; Kelm M; Schulze V
Acta Cardiol; 2020 Aug; 75(4):312-320. PubMed ID: 30983505
[No Abstract] [Full Text] [Related]
6. Left atrial appendage occlusion in patients suffering from advanced chronic kidney disease (stage 4 and 5). Long-term follow-up.
López-Tejero S; Antúnez-Muiños P; Fraile-Gómez P; Sousa GB; Rodríguez-Collado J; Herrero-Garibi J; Blanco-Fernández F; Diego-Nieto A; Delgado-Lapeira GC; Del Villar-Moro MCP; Martín-Moreiras J; Sánchez-Fernández PL; Cruz-González I
Catheter Cardiovasc Interv; 2024 Feb; 103(3):499-510. PubMed ID: 38168895
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of left atrial appendage occlusion in patients with atrial fibrillation and end stage renal disease.
Chang SN; Tsai CF; Lin TT; Chiu FC; Hsu JC; Chua SK; Cheng HL; Ho LT; Huang PS; Chen JJ; Wu CK; Wang YC; Hwang JJ; Tsai CT
J Formos Med Assoc; 2024 Jan; 123(1):116-122. PubMed ID: 37394333
[TBL] [Abstract][Full Text] [Related]
8. Sex Differences in Periprocedural and Long-Term Outcomes Following Transcatheter Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis.
Mathai SV; Sohal S; Flatow E; Nagaraj S; Hajra A; Chugh Y; Palaiodimos L; Lee HJ; Ansari J; Cohen M; Volgman AS; Faillace R
Cardiovasc Revasc Med; 2023 Mar; 48():23-31. PubMed ID: 36336589
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Combining Left Atrial Appendage Occlusion With Another Cardiac Procedure.
Ismayl M; Ahmed H; Freeman JV; Alkhouli M; Lakkireddy D; Goldsweig AM
JACC Cardiovasc Interv; 2024 Jan; 17(2):262-273. PubMed ID: 38267141
[TBL] [Abstract][Full Text] [Related]
10. [Safety and effectiveness of left atrial appendage occlusion in patients with atrial fibrillation and end-stage renal disease undergoing long-term hemodialysis].
Dai WL; Yao KX; Jiang C; Yang R; Li SN; Long DY; Jia CQ; Li X; Wu JH; Du X; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Sep; 49(9):880-885. PubMed ID: 34530595
[No Abstract] [Full Text] [Related]
11. Outcomes of cardiac surgery with left atrial appendage occlusion versus no Occlusion, direct oral Anticoagulants, and vitamin K Antagonists: A systematic review with Meta-analysis.
Nso N; Nassar M; Zirkiyeva M; Lakhdar S; Shaukat T; Guzman L; Alshamam M; Foster A; Bhangal R; Badejoko S; Lyonga Ngonge A; Tabot-Tabot M; Mbome Y; Rizzo V; Munira MS; Thambidorai S
Int J Cardiol Heart Vasc; 2022 Jun; 40():100998. PubMed ID: 35655531
[TBL] [Abstract][Full Text] [Related]
12. Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry.
Darden D; Duong T; Du C; Munir MB; Han FT; Reeves R; Saw J; Zeitler EP; Al-Khatib SM; Russo AM; Minges KE; Curtis JP; Freeman JV; Hsu JC
JAMA Cardiol; 2021 Nov; 6(11):1275-1284. PubMed ID: 34379072
[TBL] [Abstract][Full Text] [Related]
13. Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.
Gupta T; Goel K; Kolte D; Khera S; Villablanca PA; Aronow WS; Bortnick AE; Slovut DP; Taub CC; Kizer JR; Pyo RT; Abbott JD; Fonarow GC; Rihal CS; Garcia MJ; Bhatt DL
JACC Cardiovasc Interv; 2017 Oct; 10(20):2050-2060. PubMed ID: 29050621
[TBL] [Abstract][Full Text] [Related]
14. Sex differences on outcomes following left atrial appendage occlusion in atrial fibrillation: A systematic review and meta-analysis.
Zhu Y; Sasmita BR; Xue Y; Jiang Y; Huang B; Luo S
Catheter Cardiovasc Interv; 2022 Oct; 100(4):612-619. PubMed ID: 35801485
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of the presence of chronic kidney disease on percutaneous left trial appendage closure for atrial fibrillation: A single center experience.
Benini Tapias J; Flores-Umanzor E; Cepas-Guillén PL; Regueiro A; Sanchís L; Broseta JJ; Cases A; Freixa X
Nefrologia (Engl Ed); 2022; 42(3):290-300. PubMed ID: 36210618
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of left atrial appendage occlusion in atrial fibrillation patients with chronic kidney disease: a systematic review and meta-analysis.
Zhang HF; Zhang QX; Zhang YY; Yang D; Xu Z; Jiao QB; Zhang XW
Rev Cardiovasc Med; 2020 Sep; 21(3):443-451. PubMed ID: 33070548
[TBL] [Abstract][Full Text] [Related]
17. The Association of Chronic Kidney Disease With Outcomes Following Percutaneous Left Atrial Appendage Closure.
Ahuja KR; Ariss RW; Nazir S; Vyas R; Saad AM; Macciocca M; Moukarbel GV
JACC Cardiovasc Interv; 2021 Aug; 14(16):1830-1839. PubMed ID: 34412801
[TBL] [Abstract][Full Text] [Related]
18. Left Atrial Appendage Occlusion in Hereditary Haemorrhagic Telangiectasia Patients (Rendu Osler Syndrome) With Non-Valvular Atrial Fibrillation: Prevention of Cardioembolic Events While Avoiding the Long-Term Risks of Oral Anticoagulation.
Cepas-Guillen PL; López-Mínguez JR; García JCN; Nombela-Franco L; Benito-González T; Cruz-González I; Freixa X
Cardiovasc Revasc Med; 2022 Oct; 43():140-142. PubMed ID: 35513968
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and chronic kidney disease.
Michlicka-Kłyś W; Kalarus Z; Podolecki T; Mitręga K; Streb W
Postepy Kardiol Interwencyjnej; 2022 Mar; 18(1):43-49. PubMed ID: 35982742
[TBL] [Abstract][Full Text] [Related]
20. Sex Differences in the Clinical Outcomes After Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis.
Abusnina W; Latif A; Al-Abdouh A; Mostafa MR; Radaideh Q; Alshebani Y; Aboeata A; Ben-Dor I; Michos ED; Dahal K
Cardiovasc Revasc Med; 2022 Aug; 41():29-34. PubMed ID: 34952822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
